Table of Content

1 INTRODUCTION 
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 INCLUSIONS AND EXCLUSIONS 
    1.4 MARKET SCOPE 
           1.4.1 MARKET SEGMENTATION
           1.4.2 REGIONAL SCOPE
    1.5 YEARS CONSIDERED 
    1.6 CURRENCY CONSIDERED 
    1.7 STAKEHOLDERS 
    1.8 SUMMARY OF CHANGES 
           1.8.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH APPROACH 
    2.2 RESEARCH METHODOLOGY DESIGN 
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
    2.3 MARKET SIZE ESTIMATION: HEALTHCARE SIMULATION MARKET 
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.5 RESEARCH ASSUMPTIONS 
    2.6 MARKET SHARE ESTIMATION 
    2.7 LIMITATIONS 
    2.8 RISK ASSESSMENT 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
    4.1 HEALTHCARE SIMULATION MARKET OVERVIEW 
    4.2 ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 
    4.3 HEALTHCARE SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
    4.4 REGIONAL MIX: HEALTHCARE SIMULATION MARKET(2021-2028) 
    4.5 HEALTHCARE SIMULATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 INDUSTRY TRENDS 
    5.4 TECHNOLOGY ANALYSIS 
    5.5 ECOSYSTEM ANALYSIS 
    5.6 VALUE CHAIN ANALYSIS 
    5.7 PORTER’S FIVE FORCES ANALYSIS 
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 PATENT ANALYSIS 
           5.8.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE SIMULATION MARKET
           5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    5.9 TARIFF & REGULATORY LANDSCAPE 
           5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.9.2 NORTH AMERICA
           5.9.3 EUROPE
           5.9.4 ASIA PACIFIC
           5.9.4 LATIN AMERICA
           5.9.4 MIDDLE EAST AND AFRICA
    5.10 PRICING ANALYSIS 
           5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
           5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.11 KEY CONFERENCES & EVENTS IN 2023–2024 
    5.12 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.12.2 BUYING CRITERIA
    5.13 UNMET NEEDS – HEALTHCARE SIMULATION MARKET 
    5.14 CASE STUDY ANALYSIS 
    5.15 ADJACENT MARKET ANALYSIS 
    5.16 HEALTHCARE SIMULATION MARKET INVESTMENT LANDSCAPE 
6 HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE 
    6.1 INTRODUCTION 
    6.2 HEALTHCARE SIMULATION ANATOMICAL MODELS 
           6.2.1 PATIENT SIMULATORS
                    6.2.1.1 By Type
                               6.2.1.1.1 High-fidelity simulators
                               6.2.1.1.2 Medium-fidelity simulators
                               6.2.1.1.3 Low-fidelity simulators
                    6.2.1.2 By Application
                               6.2.1.2.1 Laparoscopic surgical simulators
                               6.2.1.2.2 Gynecology simulators
                               6.2.1.2.3 Cardiovascular simulators
                               6.2.1.2.4 Orthopedic surgical simulators
                               6.2.1.2.5 Spine surgical simulators
                               6.2.1.2.6 Endovascular simulators
                               6.2.1.2.7 Others
           6.2.2 TASK TRAINERS
           6.2.3 INTERVENTIONAL/SURGICAL SIMULATORS
                    6.2.3.1 Laparoscopic surgical simulators
                    6.2.3.2 Gynecology simulators
                    6.2.3.3 Cardiovascular simulators
                    6.2.3.4 Orthopedic surgical simulators
                    6.2.3.5 Spine surgical simulators
                    6.2.3.6 Endovascular simulators
                    6.2.3.7 Other surgical simulators
           6.2.4 ULTRASOUND SIMULATORS
           6.2.5 DENTAL SIMULATORS
           6.2.6 EYE SIMULATORS
    6.3 WEB-BASED SIMULATION 
    6.4 HEALTHCARE SIMULATION SOFTWARE 
    6.5 SIMULATION TRAINING SERVICES 
           6.5.1 VENDOR-BASED TRAINING
           6.5.2 EDUCATIONAL SOCIETIES
           6.5.3 CUSTOM CONSULTING SERVICES
7 HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY 
    7.1 INTRODUCTION 
    7.2 VIRTUAL PATIENT SIMULATION 
    7.3 3D PRINTING 
    7.4 PROCEDURAL REHEARSAL TECHNOLOGY 
8 HEALTHCARE SIMULATION MARKET, BY END USER 
    8.1 INTRODUCTION 
    8.2 ACADEMIC INSTITUTES 
    8.3 HOSPITALS 
    8.4 MILITARY ORGANIZATIONS 
    8.5 OTHER END USERS 
9 HEALTHCARE SIMULATION MARKET, BY REGION 
    9.1 INTRODUCTION 
    9.2 NORTH AMERICA 
           9.2.1 RECESSION IMPACT
           9.2.2 US
           9.2.3 CANADA
    9.3 EUROPE 
           9.3.1 RECESSION IMPACT
           9.3.2 UK
           9.3.3 FRANCE
           9.3.4 GERMANY
           9.3.5 ITALY
           9.3.7 SPAIN
           9.3.8 REST OF EUROPE
    9.4 ASIA PACIFIC 
           9.3.1 RECESSION IMPACT
           9.4.2 JAPAN
           9.4.3 CHINA
           9.4.4 INDIA
           9.4.5 REST OF ASIA PACIFIC
    9.5 LATIN AMERICA 
           9.3.1 RECESSION IMPACT
           9.5.2 BRAZIL
           9.5.3 MEXICO
           9.5.4 REST OF LATIN AMERICA
    9.6 MIDDLE EAST & AFRICA 
           9.3.1 RECESION IMPACT
           9.5.2 GCC COUNTRIES
           9.5.3 REST OF MIDDLE EAST AND AFRICA
10 COMPETITIVE LANDSCAPE 
     10.1 INTRODUCTION 
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 
     10.4 MARKET SHARE/RANKING ANALYSIS 
     10.5 BRAND/PRODUCT COMPARATIVE ANALYSIS 
     10.6 VALUATION AND FINANCIAL METRICS OF KEY HEALTHCARE SIMULATION VENDORS 
     10.7 COMPANY EVALUATION MATRIX 
             10.7.1 STARS
             10.7.2 EMERGING LEADERS
             10.7.3 PERVASIVE PLAYERS
             10.7.4 PARTICIPANTS
             10.7.5 COMPANY FOOTPRINT
     10.8 START-UP/SME EVALUATION MATRIX 
             10.8.1 PROGRESSIVE COMPANIES
             10.8.2 RESPONSIVE COMPANIES
             10.8.3 DYNAMIC COMPANIES 
             10.8.4 STARTING BLOCKS
             10.8.5 COMPETITIVE BENCHMARKING
     10.9 COMPETITIVE SCENARIOS AND TRENDS 
             10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
             10.9.2 DEALS
             10.9.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES 
     11.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)) *
             11.1.1 CAE INC.
             11.1.2 LAERDAL MEDICAL
             11.1.3 GAUMARD SCIENTIFIC CO.
             11.1.4 KYOTO KAGAKU
             11.1.5 LIMBS & THINGS
             11.1.6 MENTICE AB
             11.1.7 SIMULAB CORPORATION
             11.1.8 SIMULAIDS
             11.1.9 INTELLIGENT ULTRASOUND GROUP PLC
             11.1.10 OPERATIVE EXPERIENCE INC.
             11.1.11 SURGICAL SCIENCE SWEDEN AB
             11.1.12 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC)
             11.1.13 VIRTAMED AG
             11.1.14 SYNBONE AG
             11.1.15 INGMAR MEDICAL
             11.1.16 MEDICAL-X
             11.1.17 KAVO DENTAL GMBH
             11.1.18 ALTAY SCIENTIFIC
             11.1.19 TRUCORP LTD.
             11.1.20 SIMENDO B.V.
     11.2 OTHER PLAYERS 
             11.2.1 HAAG-STREIT SIMULATION
             11.2.2 SYMGERY
             11.2.3 HRV SIMULATION
             11.2.4 SYNAPTIVE MEDICAL
             11.2.5 INOVUS MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 AVAILABLE CUSTOMIZATIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS